[Federal Register Volume 65, Number 32 (Wednesday, February 16, 2000)]
[Rules and Regulations]
[Pages 7737-7744]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-3493]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 180

[OPP-300969; FRL-6490-5]
RIN 2070-AB78


Imidacloprid; Pesticide Tolerances for Emergency Exemptions

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.

-----------------------------------------------------------------------

[[Page 7738]]

SUMMARY: This regulation establishes time-limited tolerances for 
combined residues of imidacloprid and its metabolites containing the 6-
chloropyridinyl moiety, all expressed as parent in or on sweet corn 
grain, sweet corn forage and sweet corn fodder. This action is in 
response to EPA's granting of an emergency exemption under section 18 
of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 
authorizing use of the pesticide on sweet corn seed. This regulation 
establishes a maximum permissible level for residues of imidacloprid in 
this food commodity. The tolerance will expire and is revoked on 
December 31, 2001.

DATES: This regulation is effective February 16, 2000. Objections and 
requests for hearings, identified by docket control number OPP-300969, 
must be received by EPA on or before April 17, 2000.

ADDRESSES: Written objections and hearing requests may be submitted by 
mail, in person, or by courier. Please follow the detailed instructions 
for each method as provided in Unit VII. of the ``SUPPLEMENTARY 
INFORMATION.'' To ensure proper receipt by EPA, your objections and 
hearing requests must identify docket control number OPP-300969 in the 
subject line on the first page of your response.

FOR FURTHER INFORMATION CONTACT: By mail: Andrew Ertman, Registration 
Division (7505C), Office of Pesticide Programs, Environmental 
Protection Agency, Ariel Rios Bldg., 1200 Pennsylvania Ave., NW., 
Washington, DC 20460; telephone number: (703) 308-9367; and e-mail 
address: [email protected].

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does This Action Apply to Me?

    You may be potentially affected by this action if you are an 
agricultural producer, food manufacturer, or pesticide manufacturer. 
Potentially affected categories and entities may include, but are not 
limited to:

 
------------------------------------------------------------------------
                                         NAICS   Examples of potentially
              Categories                 codes      affected  entities
------------------------------------------------------------------------
Industry                                    111  Crop production.
                                            112  Animal production.
                                            311  Food manufacturing.
                                          32532  Pesticide
                                                  manufacturing.
------------------------------------------------------------------------

    This listing is not intended to be exhaustive, but rather provides 
a guide for readers regarding entities likely to be affected by this 
action. Other types of entities not listed in the table could also be 
affected. The North American Industrial Classification System (NAICS) 
codes have been provided to assist you and others in determining 
whether or not this action might apply to certain entities. If you have 
questions regarding the applicability of this action to a particular 
entity, consult the person listed under FOR FURTHER INFORMATION 
CONTACT.

B. How Can I Get Additional Information, Including Copies of This 
Document and Other Related Documents?

    1. Electronically. You may obtain electronic copies of this 
document, and certain other related documents that might be available 
electronically, from the EPA Internet Home Page at http://www.EPA.gov/. 
To access this document, on the Home Page select ``Laws and 
Regulations'' and then look up the entry for this document under the 
``Federal Register--Environmental Documents.'' You can also go directly 
to the Federal Register listings at http://www.EPA.gov/fedrgstr/.
    2. In person. The Agency has established an official record for 
this action under docket control number OPP-300969. The official record 
consists of the documents specifically referenced in this action, and 
other information related to this action, including any information 
claimed as Confidential Business Information (CBI). This official 
record includes the documents that are physically located in the 
docket, as well as the documents that are referenced in those 
documents. The public version of the official record does not include 
any information claimed as CBI. The public version of the official 
record, which includes printed, paper versions of any electronic 
comments submitted during an applicable comment period is available for 
inspection in the Public Information and Records Integrity Branch 
(PIRIB), Rm. 119, Crystal Mall 2 (CM 2), 1921 Jefferson Davis Hwy., 
Arlington, VA, from 8:30 a.m. to 4 p.m., Monday through Friday, 
excluding legal holidays. The PIRIB telephone number is (703) 305-5805.

II. Background and Statutory Findings

    EPA, on its own initiative, in accordance with sections 408(l)(6) 
of the Federal Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 346a, is 
establishing tolerances for combined residues of the insecticide 
imidacloprid and its metabolites containing the 6-chloropyridinyl 
moiety, all expressed as parent, in or on sweet corn grain at 0.05 ppm, 
sweet corn forage at 0.1 ppm, and sweet corn fodder at 0.2 ppm. These 
tolerances will expire and are revoked on December 31, 2001. EPA will 
publish a document in the Federal Register to remove the revoked 
tolerances from the Code of Federal Regulations.
    Section 408(l)(6) of the FFDCA requires EPA to establish a time-
limited tolerance or exemption from the requirement for a tolerance for 
pesticide chemical residues in food that will result from the use of a 
pesticide under an emergency exemption granted by EPA under section 18 
of FIFRA. Such tolerances can be established without providing notice 
or period for public comment. EPA does not intend for its actions on 
section 18 related tolerances to set binding precedents for the 
application of section 408 and the new safety standard to other 
tolerances and exemptions.
    Section 408(b)(2)(A)(i) of the FFDCA allows EPA to establish a 
tolerance (the legal limit for a pesticide chemical residue in or on a 
food) only if EPA determines that the tolerance is ``safe.'' Section 
408(b)(2)(A)(ii) defines ``safe'' to mean that ``there is a reasonable 
certainty that no harm will result from aggregate exposure to the 
pesticide chemical residue, including all anticipated dietary exposures 
and all other exposures for which there is reliable information.'' This 
includes exposure through drinking water and in residential settings, 
but does not include occupational exposure. Section 408(b)(2)(C) 
requires EPA to give special consideration to exposure of infants and 
children to the pesticide chemical residue in establishing a tolerance 
and to ``ensure that there is a reasonable certainty that no harm will 
result to infants and children from aggregate exposure to the pesticide 
chemical residue. . . .''
    Section 18 of the FIFRA authorizes EPA to exempt any Federal or 
State agency from any provision of FIFRA, if EPA determines that 
``emergency conditions exist which require such exemption.'' This 
provision was not amended by the Food Quality Protection Act (FQPA). 
EPA has established regulations governing such emergency exemptions in 
40 CFR part 166.

III. Emergency Exemption for Imidacloprid on Sweet Corn Seed and 
FFDCA Tolerances

    The applicants requested this use of imidacloprid to control flea 
beetles on sweet corn due to both the direct damage caused by the flea 
beetles

[[Page 7739]]

feeding on the corn (severely damged or killed corn seedlings) and the 
more important problem of the flea beetles vectoring the bacterium 
Erwinia stewartii, which causes Stewart's bacterial wilt disease in 
sweet corn. Without the use of imidacloprid, sweet corn growers would 
experience severe yield and economic losses. EPA has authorized under 
FIFRA section 18 the use of imidacloprid on sweet corn seed in 
Minnesota and Idaho. The corn seed will be authorized to planted in 
States where the corn flea beetle is creating an emergency situation. 
After having reviewed the submission, EPA concurs that emergency 
conditions exist for these States.
    As part of its assessment of this emergency exemption, EPA assessed 
the potential risks presented by residues of imidacloprid in or on 
sweet corn grain, forage, and fodder. In doing so, EPA considered the 
safety standard in FFDCA section 408(b)(2), and EPA decided that the 
necessary tolerances under FFDCA section 408(l)(6) would be consistent 
with the safety standard and with FIFRA section 18. Consistent with the 
need to move quickly on the emergency exemption in order to address an 
urgent non-routine situation and to ensure that the resulting food is 
safe and lawful, EPA is issuing these tolerances without notice and 
opportunity for public comment as provided in section 408(l)(6). 
Although these tolerances will expire and are revoked on December 31, 
2001, under FFDCA section 408(l)(5), residues of the pesticide not in 
excess of the amounts specified in the tolerances remaining in or on 
sweet corn grain, forage, and fodder after that date will not be 
unlawful, provided the pesticide is applied in a manner that was lawful 
under FIFRA, and the residues do not exceed a level that was authorized 
by this tolerance at the time of that application. EPA will take action 
to revoke this tolerance earlier if any experience with, scientific 
data on, or other relevant information on this pesticide indicate that 
the residues are not safe.
    Because these tolerances are being approved under emergency 
conditions, EPA has not made any decisions about whether imidacloprid 
meets EPA's registration requirements for use on sweet corn seed or 
whether permanent tolerances for this use would be appropriate. Under 
these circumstances, EPA does not believe that these tolerances serve 
as a basis for registration of imidacloprid by a State for special 
local needs under FIFRA section 24(c). Nor do these tolerances serve as 
the basis for any State other than Minnesota and Idaho to use this 
pesticide on this crop under section 18 of FIFRA without following all 
provisions of EPA's regulations implementing section 18 as identified 
in 40 CFR part 166. For additional information regarding the emergency 
exemption for imidacloprid, contact the Agency's Registration Division 
at the address provided under FOR FURTHER INFORMATION CONTACT.

IV. Aggregate Risk Assessment and Determination of Safety

    EPA performs a number of analyses to determine the risks from 
aggregate exposure to pesticide residues. For further discussion of the 
regulatory requirements of section 408 and a complete description of 
the risk assessment process, see the final rule on Bifenthrin Pesticide 
Tolerances (62 FR 62961, November 26, 1997) (FRL-5754-7).
    Consistent with section 408(b)(2)(D), EPA has reviewed the 
available scientific data and other relevant information in support of 
this action. EPA has sufficient data to assess the hazards of 
imidacloprid and to make a determination on aggregate exposure, 
consistent with section 408(b)(2), for a time-limited tolerance for 
combined residues of imidacloprid and its metabolites containing the 6-
chloropyridinyl moiety, all expressed as parent on sweet corn grain at 
0.05 part per million (ppm), sweet corn forage at 0.1 ppm, and sweet 
corn fodder at 0.2 ppm. EPA's assessment of the dietary exposures and 
risks associated with establishing the tolerance follows.

A. Toxicological Profile

    EPA has evaluated the available toxicity data and considered its 
validity, completeness, and reliability as well as the relationship of 
the results of the studies to human risk. EPA has also considered 
available information concerning the variability of the sensitivities 
of major identifiable subgroups of consumers, including infants and 
children. The nature of the toxic effects caused by imidacloprid are 
discussed in this unit.

B. Toxicological Endpoint

    Only acute and chronic dietary endpoints were defined. The 10X FQPA 
factor was reduced to 3X for acute and chronic exposure, and applies to 
all population subgroups.
    1. Acute toxicity. The acute Reference Dose (RfD) is 0.42 
milligrams/kilograms/body weight/day (mg/kg bwt/day) based on a lowest 
observed adverse effect level (LOAEL) of 42 mg/kg bwt/day based on 
decreased motor activity in female rats. An additional 3X FQPA factor 
was incorporated for all population subgroups to account for 
neurotoxicity, structure-activity concerns and lack of a no observed 
adverse effect level (NOAEL). The acute population adjusted dose 
(aPAD), which is the RfD/3 was calculated to be 0.14 mg/kg bwt/day. 
Acceptable acute dietary exposure (food plus water) of 100% or less of 
the aPAD is required for all population subgroups.
    2. Short- and intermediate-term toxicity. Dermal and inhalation 
short- and intermediate-term risk assessments are not required for 
imidacloprid as dermal and inhalation exposure endpoints were not 
identified due to the demonstrated absence of toxicity, however, 
because imidacloprid is registered for use on turf, home gardens and 
pets, EPA has identified potential short-term oral exposures to 
children for these uses.
    A short-term oral endpoint was not identified for imidacloprid. 
According to current OPP policy, if an oral endpoint is needed for 
short-term risk assessment (for incorporation of food, water, or oral 
hand-to-mouth type exposures into an aggregate risk assessment), the 
acute oral endpoint (LOAEL = 42 mg/kg bwt/day) will be used to 
incorporate the oral component into aggregate risk.
    3. Chronic toxicity. EPA has established the RfD for imidacloprid 
at 0.057 mg/kg/day. This RfD is based on increased number of thyroid 
lesions at the LOAEL of 16.9/24.9 mg/kg bwt/day (males & females, 
respectively). An additional 3X FQPA factor was used for all population 
subgroups. The chronic population adjusted dose (cPAD), which is the 
RfD/3 was calculated to be 0.019 mg/kg bwt/day. Acceptable chronic 
dietary exposure (food plus water) of 100% or less of the cPAD is 
required for all population subgroups.
    4. Carcinogenicity. Imidacloprid has been classified by the Agency 
as a Group E chemical, no evidence of carcinogenicity for humans, thus, 
a cancer risk assessment is not required.

C. Exposures and Risks

    1. From food and feed uses. Tolerances, some time-limited, are 
currently established (40 CFR 180.472) for the combined residues of the 
insecticide imidacloprid and its metabolites containing the 6-
chloropyridinyl moiety, all expressed as parent, in or on a variety of 
raw agricultural and animal commodities at levels ranging from 0.02 ppm 
in eggs to 15 ppm in raisins, waste. Risk assessments were conducted by 
EPA to

[[Page 7740]]

assess dietary exposures and risks from imidacloprid as follows:
    i. Acute exposure and risk. Acute dietary risk assessments are 
performed for a food-use pesticide if a toxicological study has 
indicated the possibility of an effect of concern occurring as a result 
of a 1-day or single exposure.
    In conducting the acute dietary (food) risk assessment, EPA used 
the Theoretical Maximum Residue Contribution (TMRC) which assumes 
tolerance level residues and 100% crop-treated (Tier 1). The analysis 
evaluates individual food consumption as reported by respondents in the 
USDA Continuing Surveys of Food Intake by Individuals conducted in 1989 
through 1992. The model accumulates exposure to the chemical for each 
commodity and expresses risk as a function of dietary exposure. 
Resulting exposure values (at the 95th percentile) and percentage of 
aPAD utilized ranged from 22% for the United States (U.S.) population 
to 44% for children 1-6 years old.
    ii. Chronic exposure and risk. In conducting the chronic dietary 
(food only) risk assessment, EPA used: (1) Tolerance level residues for 
imidacloprid; and, (2) percent crop-treated (PCT) information for some 
of these crops. The analysis evaluates individual food consumption as 
reported by respondents in the USDA Continuing Surveys of Food Intake 
by Individuals conducted in 1989 through 1992. The percentages of cPAD 
consumed for the general population and subgroups of interest ranged 
from 9.2% for nursing infants 1 year old to 48.5% for children 1-6 
years old.
    Section 408(b)(2)(E) authorizes EPA to use available data and 
information on the anticipated residue levels of pesticide residues in 
food and the actual levels of pesticide chemicals that have been 
measured in food. If EPA relies on such information, EPA must require 
that data be provided 5 years after the tolerance is established, 
modified, or left in effect, demonstrating that the levels in food are 
not above the levels anticipated. Following the initial data 
submission, EPA is authorized to require similar data on a time frame 
it deems appropriate. As required by section 408(b)(2)(E), EPA will 
issue a data call-in for information relating to anticipated residues 
to be submitted no later than 5 years from the date of issuance of this 
tolerance.
    Section 408(b)(2)(F) states that the Agency may use data on the 
actual percent of food treated for assessing chronic dietary risk only 
if the Agency can make the following findings: Condition 1, that the 
data used are reliable and provide a valid basis to show what 
percentage of the food derived from such crop is likely to contain such 
pesticide residue; Condition 2, that the exposure estimate does not 
underestimate exposure for any significant subpopulation group; and 
Condition 3, if data are available on pesticide use and food 
consumption in a particular area, the exposure estimate does not 
understate exposure for the population in such area. In addition, the 
Agency must provide for periodic evaluation of any estimates used. To 
provide for the periodic evaluation of the estimate of PCT as required 
by section 408(b)(2)(F), EPA may require registrants to submit data on 
PCT.
    The Agency used PCT information as follows.
    The Agency believes that the three conditions listed above have 
been met. With respect to Condition 1, PCT estimates are derived from 
Federal and private market survey data, which are reliable and have a 
valid basis. EPA uses a weighted average PCT for chronic dietary 
exposure estimates. This weighted average PCT figure is derived by 
averaging State-level data for a period of up to 10 years, and 
weighting for the more robust and recent data. A weighted average of 
the PCT reasonably represents a person's dietary exposure over a 
lifetime, and is unlikely to underestimate exposure to an individual 
because of the fact that pesticide use patterns (both regionally and 
nationally) tend to change continuously over time, such that an 
individual is unlikely to be exposed to more than the average PCT over 
a lifetime. For acute dietary exposure estimates, EPA uses an estimated 
maximum PCT. The exposure estimates resulting from this approach 
reasonably represent the highest levels to which an individual could be 
exposed, and are unlikely to underestimate an individual's acute 
dietary exposure. The Agency is reasonably certain that the percentage 
of the food treated is not likely to be an underestimated. As to 
Conditions 2 and 3, regional consumption information and consumption 
information for significant subpopulations is taken into account 
through EPA's computer-based model for evaluating the exposure of 
significant subpopulations including several regional groups. Use of 
this consumption information in EPA's risk assessment process ensures 
that EPA's exposure estimate does not understate exposure for any 
significant subpopulation group and allows the Agency to be reasonably 
certain that no regional population is exposed to residue levels higher 
than those estimated by the Agency. Other than the data available 
through national food consumption surveys, EPA does not have available 
information on the regional consumption of food to which imidacloprid 
may be applied in a particular area.
    2. From drinking water. There is no established Maximum Contaminant 
Level for residues of imidacloprid in drinking water. No health 
advisory levels for imidacloprid in drinking water have been 
established.
    Imidacloprid is persistent, water soluble, and fairly mobile. Thus, 
residues of imidacloprid may be transported to both surface and ground 
waters. As a condition of registration, the Agency is requiring the 
submission of the results of two prospective ground water monitoring 
studies. Results from these studies are not yet available.
    i. Acute exposure and risk. Estimated concentrations of 
imidacloprid in surface and ground water used for the acute exposure 
analysis were 4.1 and 1.1 g/L (ppb), respectively. These 
estimated concentrations of imidacloprid in surface and ground water 
were based upon an application rate of 0.5 lbs ai/A/year.
    For purposes of risk assessment, the estimated maximum 
concentration for imidacloprid in surface and ground waters (which is 
4.1 g/L) should be used for comparison to the back-calculated 
human health drinking water levels of concern (DWLOCs) for the acute 
endpoint. The DWLOCs ranged from 780 g/L for children 1-6 
years old to 3,900 g/L for the U.S. population. These figures 
are well above the drinking water estimate concentration (DWEC) of 4.1 
g/L.
    ii. Chronic exposure and risk. Estimated concentrations of 
imidacloprid in surface and ground water for chronic exposure analysis 
were 0.1 and 1.1 g/L (ppb), respectively. These estimated 
concentrations of imidacloprid in surface and ground water were based 
upon an application rate of 0.5 lbs ai/A/year.
    For purposes of chronic risk assessment, the estimated maximum 
concentration for imidacloprid in ground waters (which is 1.1 
g/L) should be used for comparison to the back-calculated 
human health DWLOCs for the chronic (non-cancer) endpoint. The DWLOCs 
ranged from 98 g/L for children 1-6 years old to 490 
g/L for Non-hispanic males (other than black or white). These 
figures are well above the DWEC of 1.1 g/L.
    3. From non-dietary exposure. Imidacloprid is currently registered 
for use on the following residential non-food sites: ornamentals (e.g., 
flowering and foliage plants, ground covers, turf,

[[Page 7741]]

lawns, et al.), tobacco, golf courses, walkways, recreational areas, 
household or domestic dwellings (indoor/outdoor), and cats/dogs.
    i. Acute exposure and risk. Occupational/residential exposure risk 
assessments (namely, short-term dermal, intermediate-term dermal, long-
term dermal, and inhalation) are not required owing to the demonstrated 
absence of dermal and inhalation toxicity.
    ii. Chronic exposure and risk. Occupational/residential exposure 
risk assessments (namely, short-term dermal, intermediate-term dermal, 
long-term dermal, and inhalation) are not required owing to the 
demonstrated absence of dermal and inhalation toxicity.
    iii. Short- and intermediate-term exposure and risk. Short- and 
intermediate-term oral exposure are not expected for adult population 
subgroups. However, since imidacloprid is registered for use on turf, 
home gardens and pets, EPA has identified potential short-term oral 
exposures to children for these uses. Thus, a residential short-term 
risk assessment via the oral route is required. See section III(E)(4) 
for a full discussion of this exposure and risk.
    4. Cumulative exposure to substances with a common mechanism of 
toxicity. Section 408(b)(2)(D)(v) requires that, when considering 
whether to establish, modify, or revoke a tolerance, the Agency 
consider ``available information'' concerning the cumulative effects of 
a particular pesticide's residues and ``other substances that have a 
common mechanism of toxicity.''
    EPA does not have, at this time, available data to determine 
whether imidacloprid has a common mechanism of toxicity with other 
substances or how to include this pesticide in a cumulative risk 
assessment. Unlike other pesticides for which EPA has followed a 
cumulative risk approach based on a common mechanism of toxicity, 
imidacloprid does not appear to produce a toxic metabolite produced by 
other substances. For the purposes of this tolerance action, therefore, 
EPA has not assumed that imidacloprid has a common mechanism of 
toxicity with other substances. For more information regarding EPA's 
efforts to determine which chemicals have a common mechanism of 
toxicity and to evaluate the cumulative effects of such chemicals, see 
the final rule for Bifenthrin Pesticide Tolerances (62 FR 62961, 
November 26, 1997).

D. Aggregate Risks and Determination of Safety for U.S. Population

    1. Acute risk. EPA has determined that the acute exposure to 
imidacloprid from food will utilize 22% of the aPAD (95th percentile) 
for the most highly exposed population subgroup (U.S. population - all 
seasons). Despite the potential for exposure to imidacloprid in 
drinking water, the Agency does not expect the aggregate exposure to 
exceed 100% of the aPAD. The DWLOC calculated for the U.S. population 
was 3900 g/L, which is well above the DWEC of 4.1 g/
L.
    2. Chronic risk. In conducting the chronic dietary (food only) risk 
assessment, EPA used: (1) tolerance level residues for imidacloprid; 
and, (2) PCT information for some of these crops. The analysis 
evaluates individual food consumption as reported by respondents in the 
USDA Continuing Surveys of Food Intake by Individuals conducted in 1989 
through 1992. The percentage of cPAD consumed for the U.S. population 
was 22%. The major identifiable subgroup with the highest aggregate 
exposure is discussed below. EPA generally has no concern for exposures 
below 100% of the cPAD because the cPAD represents the level at or 
below which daily aggregate dietary exposure over a lifetime will not 
pose appreciable risks to human health. Despite the potential for 
exposure to imidacloprid in drinking water, the Agency does not expect 
the aggregate exposure to exceed 100% of the cPAD. The DWLOC calculated 
for the U.S. population was well above the DWEC of 1.1 g/L.
    3. Short- and intermediate-term risk. Short- and intermediate-term 
aggregate exposure takes into account chronic dietary food and water 
(considered to be a background exposure level) plus indoor and outdoor 
residential exposure.
    Dermal and inhalation short- and intermediate term risk assessments 
are not required for imidacloprid as dermal and inhalation exposure 
endpoints were not identified due to the demonstrated absence of 
toxicity. Short- and intermediate-term oral exposure are not expected 
for adult population subgroups. A discussion of short and intermediate 
term oral exposure and risk for children 1-6 can be found in section 
III(E)(4).
    4. Aggregate cancer risk for U.S. population. Imidacloprid has been 
classified as a Group E chemical, no evidence of carcinogenicity for 
humans, thus, a cancer risk assessment is not required.
    5. Determination of safety. Based on these risk assessments, EPA 
concludes that there is a reasonable certainty that no harm will result 
from aggregate exposure to imidacloprid residues.

E. Aggregate Risks and Determination of Safety for Infants and Children

    1. Safety factor for infants and children-- i. In general. In 
assessing the potential for additional sensitivity of infants and 
children to residues of imidacloprid, EPA considered data from 
developmental toxicity studies in the rat and rabbit and a 2-generation 
reproduction study in the rat. The developmental toxicity studies are 
designed to evaluate adverse effects on the developing organism 
resulting from maternal pesticide exposure during gestation. 
Reproduction studies provide information relating to effects from 
exposure to the pesticide on the reproductive capability of mating 
animals and data on systemic toxicity.
    FFDCA section 408 provides that EPA shall apply an additional 
tenfold margin of safety for infants and children in the case of 
threshold effects to account for prenatal and postnatal toxicity and 
the completeness of the data base unless EPA determines that a 
different margin of safety will be safe for infants and children. 
Margins of safety are incorporated into EPA risk assessments either 
directly through use of a margin of exposure (MOE) analysis or through 
using uncertainty (safety) factors in calculating a dose level that 
poses no appreciable risk to humans. EPA believes that reliable data 
support using the standard MOE and uncertainty factor (usually 100 for 
combined interspecies and intraspecies variability) and not the 
additional tenfold MOE/uncertainty factor when EPA has a complete data 
base under existing guidelines and when the severity of the effect in 
infants or children or the potency or unusual toxic properties of a 
compound do not raise concerns regarding the adequacy of the standard 
MOE/safety factor.
    ii. Developmental toxicity studies. In a developmental toxicity 
study with Sprague-Dawley rats, groups of pregnant animals (25/group) 
received oral administration of imidacloprid (94.2%) at 0, 10, 30, or 
100 mg/kg bwt/day during gestation days 6 through 16. Maternal toxicity 
was manifested as decreased body weight gain at all dose levels and 
reduced food consumption at 100 mg/kg bwt/day. No treatment-related 
effects were seen in any of the reproductive parameters (i.e., Cesarean 
section evaluation). At 100 mg/kg bwt/day, developmental toxicity 
manifested as wavy ribs (fetus =7/149 in treated vs. 2/158 in controls 
and litters, 4/25 vs. 1/25). For maternal toxicity, the LOAEL was 10 
mg/kg bwt/day lowest dose tested (LDT) based on decreased body weight 
gain; a NOAEL was not

[[Page 7742]]

established. For developmental toxicity, the NOAEL was 30 mg/kg bwt/day 
and the LOAEL was 100 mg/kg bwt/day based on increased wavy ribs.
    In a developmental toxicity study with Chinchilla rabbits, groups 
of 16 pregnant does were given oral doses of imidacloprid (94.2%) at 0, 
8, 24 or 72 mg/kg bwt/day during gestation days 6 through 18. For 
maternal toxicity, the NOAEL was 24 mg/kg bwt/day and the LOAEL was 72 
mg/kg bwt/day based on mortality, decreased body weight gain, increased 
resorptions, and increased abortions. For developmental toxicity, the 
NOAEL was 24 mg/kg bwt/day and the LOAEL was 72 mg/kg bwt/day based on 
decreased fetal body weight, increased resorptions, and increased 
skeletal abnormalities.
    iii. Reproductive toxicity study. In a 2-generation reproductive 
toxicity study, imidacloprid (95.3%) was administered to Wistar/Han 
rats at dietary levels of 0, 100, 250, or 700 ppm (0, 7.3, 18.3, or 
52.0 mg/kg bwt/day for males and 0, 8.0, 20.5, or 57.4 mg/kg bwt/day 
for females). For parental/systemic/reproductive toxicity, the NOAEL 
was 250 ppm (18.3 mg/kg bwt/day) and the LOAEL was 750 ppm (52 mg/kg 
bwt/day), based on decreases in body weight in both sexes in both 
generations. Based on these factors, the Agency determined that the 
review be revised to indicate the parental/systemic/reproductive NOAEL 
and LOAEL to be 250 and 700 ppm, respectively, based upon the body 
weight decrements observed in both sexes in both generations.
    iv. Prenatal and postnatal sensitivity. The developmental toxicity 
data demonstrated no increased sensitivity of rats or rabbits to in 
utero exposure to imidacloprid. In addition, the multi-generation 
reproductive toxicity study data did not identify any increased 
sensitivity of rats to in utero or postnatal exposure. Parental NOAELs 
were lower or equivalent to developmental or offspring NOAELs.
    v. Conclusion. There is a need for a developmental neurotoxicity 
study for assessment of potential alterations of functional 
development. However, the Agency has determined that this data gap does 
not preclude the establishment/continuance of tolerances. The 10X 
safety factor to account for enhanced sensitivity of infants and 
children (as required by FQPA) was reduced to 3X and the factor applies 
to all population subgroups.
    2. Acute risk. Using the conservative TMRC exposure assumptions 
described above, and taking into account the completeness and 
reliability of the toxicity data, EPA has estimated the acute exposure 
to imidacloprid from food for the most highly exposed population 
subgroup (Children 1-6 years) will utilize 44% of the aPAD. It was 
determined that an acceptable acute dietary exposure (food plus water) 
of 100% or less of the aPAD is needed to protect the safety of all 
population subgroups. Despite the potential for exposure to 
imidacloprid in drinking water, EPA does not expect the aggregate 
exposure to exceed 100% of the aPAD for children 1-6 years old. The 
maximum concentration of imidacloprid in surface and ground water for 
acute exposure is very small (4.1 g/L) compared to the DWEC of 
780 g/L.
    3. Chronic risk. Using the exposure assumptions described in this 
unit, EPA has concluded that aggregate exposure to imidacloprid from 
food will utilize 48% of the cPAD for infants and children. EPA 
generally has no concern for exposures below 100% of the cPAD because 
the cPAD represents the level at or below which daily aggregate dietary 
exposure over a lifetime will not pose appreciable risks to human 
health. Despite the potential for exposure to imidacloprid in drinking 
water, EPA does not expect the aggregate exposure to exceed 100% of the 
cPAD for children 1-6 years old. The maximum concentration of 
imidacloprid in surface and ground water for acute exposure is very 
small (1.1 g/L) compared to the DWEC of 98 g/L.
    4. Short- or intermediate-term risk. As noted earlier in this 
document, dermal and inhalation short- and intermediate term risk 
assessments are not required for imidacloprid as dermal and inhalation 
exposure endpoints were not identified due to the demonstrated absence 
of toxicity. Short- and intermediate-term oral exposure are not 
expected for adult population subgroups. However, since imidacloprid is 
registered for use on turf, home gardens and pets, EPA has identified 
potential short-term oral exposures to children for these uses.
    A short-term oral endpoint was not identified for imidacloprid. 
According to current OPP policy, if an oral endpoint is needed for 
short-term risk assessment (for incorporation of food, water, or oral 
hand-to-mouth type exposures into an aggregate risk assessment), the 
acute oral endpoint (LOAEL = 42 mg/kg bwt/day) will be used to 
incorporate the oral component into aggregate risk.
    The margin of exposure for chronic dietary exposure (food only) and 
residential exposure (hand-to-mouth from turf, garden, and pet uses) 
for children age 1-6 was calculated to be 302. The safe level for 
imidacloprid is 300.
    Potential short-term exposure from drinking water is at a level 
below the Agency's level of concern with the DWLOC (10 g/L) 
being greater than the DWEC of 1.1 g/L.
    The Agency concludes the short-term aggregate risk to the highest 
exposed population subgroup (children, 1 to 6 years old) from home 
garden, turf, and pet uses of imidacloprid does not exceed EPA's level 
of concern.
    5. Determination of safety. Based on these risk assessments, EPA 
concludes that there is a reasonable certainty that no harm will result 
to infants and children from aggregate exposure to imidacloprid 
residues.

V. Other Considerations

A. Metabolism in Plants and Animals

    The nature of imidacloprid residues in plants and in animals is 
adequately understood. The residue of concern is imidacloprid and its 
metabolites containing the 6-chloropyridinyl moiety, all expressed as 
parent, as specified in 40 CFR 180.472.

B. Analytical Enforcement Methodology

    Adequate enforcement methodology is available to enforce the 
tolerance expression. The method may be requested from: Calvin Furlow, 
PIRIB, IRSD (7502C), Office of Pesticide Programs, Environmental 
Protection Agency, Ariel Rios Bldg., 1200 Pennsylvania Ave., NW., 
Washington, DC 20460; telephone number: (703) 305-5229; e-mail address: 
[email protected].

C. Magnitude of Residues

    Crop field trials on field corn seed treatment (with the same use 
rate as on sweet corn seeds) have been submitted), and residues of 
imidacloprid are not expected to exceed 0.05 ppm in corn grain, 0.1 ppm 
in forage, and 0.2 ppm in fodder. The Agency has translated these 
residue results to sweet corn, and thus, residues of imidacloprid are 
not expected to exceed 0.05 ppm in sweet corn grain, 0.1 ppm in forage, 
and 0.2 ppm in fodder with its use on sweet corn seed.

D. International Residue Limits

    There are no CODEX, Canadian, or Mexican Maximum Residue Limits 
(MRL) for imidacloprid on sweet corn. Thus, harmonization is not an 
issue for these time limited tolerances.

E. Rotational Crop Restrictions

    The rotational crop restrictions follow the original section 3 
labels.

[[Page 7743]]

VI. Conclusion

    Therefore, the tolerance is established for the combined residues 
of imidacloprid and its metabolites containing the 6-chloropyridinyl 
moiety, all expressed as parent on sweet corn grain at 0.05 ppm, sweet 
corn forage at 0.1 ppm, and sweet corn fodder at 0.2 ppm.

VII. Objections and Hearing Requests

    Under section 408(g) of the FFDCA, as amended by the FQPA, any 
person may file an objection to any aspect of this regulation and may 
also request a hearing on those objections. The EPA procedural 
regulations which govern the submission of objections and requests for 
hearings appear in 40 CFR part 178. Although the procedures in those 
regulations require some modification to reflect the amendments made to 
the FFDCA by the FQPA of 1996, EPA will continue to use those 
procedures, with appropriate adjustments, until the necessary 
modifications can be made. The new section 408(g) provides essentially 
the same process for persons to ``object'' to a regulation for an 
exemption from the requirement of a tolerance issued by EPA under new 
section 408(d), as was provided in the old FFDCA sections 408 and 409. 
However, the period for filing objections is now 60 days, rather than 
30 days.

A. What Do I Need to Do to File an Objection or Request a Hearing?

    You must file your objection or request a hearing on this 
regulation in accordance with the instructions provided in this unit 
and in 40 CFR part 178. To ensure proper receipt by EPA, you must 
identify docket control number OPP-300969 in the subject line on the 
first page of your submission. All requests must be in writing, and 
must be mailed or delivered to the Hearing Clerk on or before April 17, 
2000.
    1. Filing the request. Your objection must specify the specific 
provisions in the regulation that you object to, and the grounds for 
the objections (40 CFR 178.25). If a hearing is requested, the 
objections must include a statement of the factual issues(s) on which a 
hearing is requested, the requestor's contentions on such issues, and a 
summary of any evidence relied upon by the objector (40 CFR 178.27). 
Information submitted in connection with an objection or hearing 
request may be claimed confidential by marking any part or all of that 
information as CBI. Information so marked will not be disclosed except 
in accordance with procedures set forth in 40 CFR part 2. A copy of the 
information that does not contain CBI must be submitted for inclusion 
in the public record. Information not marked confidential may be 
disclosed publicly by EPA without prior notice.
    Mail your written request to: Office of the Hearing Clerk (1900), 
Environmental Protection Agency, Ariel Rios Bldg., 1200 Pennsylvania 
Ave., NW., Washington, DC 20460. You may also deliver your request to 
the Office of the Hearing Clerk in Rm. M3708, Waterside Mall, 401 M 
St., SW., Washington, DC 20460. The Office of the Hearing Clerk is open 
from 8 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. 
The telephone number for the Office of the Hearing Clerk is (202) 260-
4865.
    2. Tolerance fee payment. If you file an objection or request a 
hearing, you must also pay the fee prescribed by 40 CFR 180.33(i) or 
request a waiver of that fee pursuant to 40 CFR 180.33(m). You must 
mail the fee to: EPA Headquarters Accounting Operations Branch, Office 
of Pesticide Programs, P.O. Box 360277M, Pittsburgh, PA 15251. Please 
identify the fee submission by labeling it ``Tolerance Petition Fees.''
    EPA is authorized to waive any fee requirement ``when in the 
judgement of the Administrator such a waiver or refund is equitable and 
not contrary to the purpose of this subsection.'' For additional 
information regarding the waiver of these fees, you may contact James 
Tompkins by phone at (703) 305-5697, by e-mail at [email protected], 
or by mailing a request for information to Mr. Tompkins at Registration 
Division (7505C), Office of Pesticide Programs, Environmental 
Protection Agency, Ariel Rios Bldg., 1200 Pennsylvania Ave., NW., 
Washington, DC 20460.
    If you would like to request a waiver of the tolerance objection 
fees, you must mail your request for such a waiver to: James Hollins, 
Information Resources and Services Division (7502C), Office of 
Pesticide Programs, Environmental Protection Agency, Ariel Rios Bldg., 
1200 Pennsylvania Ave., NW., Washington, DC 20460.
    3. Copies for the Docket. In addition to filing an objection or 
hearing request with the Hearing Clerk as described in Unit VII.A., you 
should also send a copy of your request to the PIRIB for its inclusion 
in the official record that is described in Unit I.B.2. Mail your 
copies, identified by the docket control number OPP-300969, to: Public 
Information and Records Integrity Branch, Information Resources and 
Services Division (7502C), Office of Pesticide Programs, Environmental 
Protection Agency, Ariel Rios Bldg., 1200 Pennsylvania Ave., NW., 
Washington, DC 20460.
    In person or by courier, bring a copy to the location of the PIRIB 
described in Unit I.B.2. You may also send an electronic copy of your 
request via e-mail to: [email protected]. Please use an ASCII file 
format and avoid the use of special characters and any form of 
encryption. Copies of electronic objections and hearing requests will 
also be accepted on disks in WordPerfect 6.1/8.0 file format or ASCII 
file format. Do not include any CBI in your electronic copy. You may 
also submit an electronic copy of your request at many Federal 
Depository Libraries.

B. When Will the Agency Grant a Request for a Hearing?

    A request for a hearing will be granted if the Administrator 
determines that the material submitted shows the following: There is a 
genuine and substantial issue of fact; there is a reasonable 
possibility that available evidence identified by the requestor would, 
if established resolve one or more of such issues in favor of the 
requestor, taking into account uncontested claims or facts to the 
contrary; and resolution of the factual issues(s) in the manner sought 
by the requestor would be adequate to justify the action requested (40 
CFR 178.32).

VIII. Regulatory Assessment Requirements

    This final rule establishes time limited tolerances under FFDCA 
section 408. The Office of Management and Budget (OMB) has exempted 
these types of actions from review under Executive Order 12866, 
entitled Regulatory Planning and Review (58 FR 51735, October 4, 1993). 
This final rule does not contain any information collections subject to 
OMB approval under the Paperwork Reduction Act (PRA), 44 U.S.C. 3501 et 
seq., or impose any enforceable duty or contain any unfunded mandate as 
described under Title II of the Unfunded Mandates Reform Act of 1995 
(UMRA) (Public Law 104-4). Nor does it require any prior consultation 
as specified by Executive Order 13084, entitled Consultation and 
Coordination with Indian Tribal Governments (63 FR 27655, May 19, 
1998); special considerations as required by Executive Order 12898, 
entitled Federal Actions to Address Environmental Justice in Minority 
Populations and Low-Income Populations (59 FR 7629, February 16, 1994); 
or require OMB review or any Agency action under Executive Order 13045, 
entitled Protection of Children from Environmental Health Risks and 
Safety Risks (62 FR 19885, April 23,

[[Page 7744]]

1997). This action does not involve any technical standards that would 
require Agency consideration of voluntary consensus standards pursuant 
to section 12(d) of the National Technology Transfer and Advancement 
Act of 1995 (NTTAA), Public Law 104-113, section 12(d) (15 U.S.C. 272 
note). Since tolerances and exemptions that are established on the 
basis of a FIFRA section 18 petition under FFDCA section 408, such as 
the tolerances in this final rule, do not require the issuance of a 
proposed rule, the requirements of the Regulatory Flexibility Act (RFA) 
(5 U.S.C. 601 et seq.) do not apply. In addition, the Agency has 
determined that this action will not have a substantial direct effect 
on States, on the relationship between the national government and the 
States, or on the distribution of power and responsibilities among the 
various levels of government, as specified in Executive Order 13132, 
entitled Federalism (64 FR 43255, August 10, 1999). Executive Order 
13132 requires EPA to develop an accountable process to ensure 
``meaningful and timely input by State and local officials in the 
development of regulatory policies that have federalism implications.'' 
``Policies that have federalism implications'' is defined in the 
Executive Order to include regulations that have ``substantial direct 
effects on the States, on the relationship between the national 
government and the States, or on the distribution of power and 
responsibilities among the various levels of government.'' This final 
rule directly regulates growers, food processors, food handlers and 
food retailers, not States. This action does not alter the 
relationships or distribution of power and responsibilities established 
by Congress in the preemption provisions of FFDCA section 408(n)(4).

IX. Submission to Congress and the Comptroller General

    The Congressional Review Act, 5 U.S.C. 801 et seq., as added by the 
Small Business Regulatory Enforcement Fairness Act of 1996, generally 
provides that before a rule may take effect, the agency promulgating 
the rule must submit a rule report, which includes a copy of the rule, 
to each House of the Congress and to the Comptroller General of the 
United States. EPA will submit a report containing this rule and other 
required information to the U.S. Senate, the U.S. House of 
Representatives, and the Comptroller General of the United States prior 
to publication of this final rule in the Federal Register. This final 
rule is not a ``major rule'' as defined by 5 U.S.C. 804(2).

List of Subjects in 40 CFR Part 180

    Environmental protection, Administrative practice and procedure, 
Agricultural commodities, Pesticides and pests, Reporting and 
recordkeeping requirements.

    Dated: February 8, 2000.
James Jones,
Director, Registration Division, Office of Pesticide Programs.
    Therefore, 40 CFR chapter I is amended as follows:

PART 180--[AMENDED]

    1. The authority citation for part 180 continues to read as 
follows:

    Authority: 21 U.S.C. 321(q), 346(a) and 371.
    2. In Sec. 180.472, by alphabetically adding the following 
commodities to the table in paragraph (b) to read as follows:


Sec. 180.472  Imidacloprid; tolerances for residues.

        *    *    *    *    *
    (b)    *    *    *

 
------------------------------------------------------------------------
                                                             Expiration/
                   Commodity                     Parts per    revocation
                                                  million        date
------------------------------------------------------------------------
 
                   *    *    *    *    *    *    *
Sweet corn, fodder............................          0.2     12/31/01
Sweet corn, forage............................          0.1     12/31/01
Sweet corn, grain.............................         0.05     12/31/01
 
                   *    *    *    *    *    *    *
------------------------------------------------------------------------

        *    *    *    *      *
[FR Doc. 00-3493 Filed 2-15-00; 8:45 am]
BILLING CODE 6560-50-F